CCEL
Cryo-Cell International, Inc.Healthcare·Medical - Care Facilities
$3.37
$27M market cap
Revenue
$15.5M
Free Cash Flow
$1.8M
Rev Growth
+0.0%
FCF Margin
11.6%
P/FCF
15.1x
EV/FCF
14.8x
Fwd EV/EBITDA
--
Fair Value
--
Upside
--
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures an
2-Year Price History
$3.46-58.9%
Quarterly Financials & Projections
Quarterly Waterfall ($ M)
| Period | Rev | EBITDA | OpIn | NI | OCF | FCF | CapEx | Cash | Debt | Shares | ROIC | IntCov | EV/EBITDA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Act | 2026-Q1 | 7.7 | 0.9 | 0.8 | 0.1 | 0.7 | 0.6 | -0.1 | 2.9 | 2.4 | 8.1 | 114.1% | 1.9x | -- |
| Act | 2025-Q4 | 7.8 | -4.4 | -4.0 | -4.7 | 1.3 | 1.2 | -0.1 | 3.3 | 3.2 | 8.1 | -495.1% | -9.2x | -- |
Valuation & Metrics
Market Stats
Price$3.37
Market Cap$27M
Enterprise Value$27M
P/S Ratio1.8x
P/FCF15.1x
EV/FCF14.8x
FCF Margin (TTM)11.6%
FCF Yield6.6%
Dividend Yield (TTM)19.3%
Annual Dilution0.0%
CurrencyUSD
TTM Financial Snapshot
Revenue$15.5M
Net Income$-4.6M
Free Cash Flow$1.8M
Revenue Growth (YoY)+0.0%
EBITDA Margin-22.8%
Net Margin-29.9%
FCF Margin11.6%
CapEx % of Revenue0.9%
SBC % of Revenue1.3%
ROIC-190.5%
WC Change % Rev-40.8%
Interest Coverage-3.8x
Forward Outlook & Risk
Short Interest
Short % of Float--
Short Shares0.0M
Days to Cover1.0
Change (vs Prior)-11.6%
Need at least 2 settlement dates for chart
Employees
Headcount82
Revenue / Employee$189,345
Gross Profit / Employee$147,996
Institutional Ownership
Headline & net flow
NEUTRAL
Net flow · —still filing
No float data — flow unavailable.
Ownership composition
Active
3.5%(-15.0% YoY)
6 filers
hedge / family / endowment
Retail funds
—
Fidelity, Schwab, 401(k)
Passive
3.1%(-1.8% YoY)
4 filers
Vanguard, iShares, SPDR
Market makers
0.1%(+0.1% YoY)
1 filers
Citadel, Susquehanna
Insiders
—
Form 4 — latest per insider
ActiveRetail fundsPassiveMarket makersRetail direct
Top holders
| Fund | $ value | Cost basis | Δ QoQ | Δ YoY | α life | Fund AUM |
|---|---|---|---|---|---|---|
| SFI Advisors, LLC | $587K | $4.73 | +$0 | +$0 | +0.2% | $95.2M |
| VANGUARD CAPITAL MANAGEMENT LLCPassive | $573K | $3.55 | +$573K | +$573K | — | $4.04T |
| MassMutual Private Wealth & Trust, FSB | $394K | $4.73 | +$0 | +$0 | -0.1% | $3.67B |
| GEODE CAPITAL MANAGEMENT, LLCPassive | $155K | $5.61 | −$34K | −$6K | +2.3% | $1.61T |
| VANGUARD FIDUCIARY TRUST COPassive | $83K | $3.55 | +$83K | +$83K | — | $395.83B |
| BlackRock, Inc.Passive | $50K | $5.57 | +$4K | +$2K | -0.2% | $5.69T |
| SUSQUEHANNA INTERNATIONAL GROUP, LLPMM | $36K | $4.52 | −$8K | +$36K | -0.6% | $77.14B |
| ADVISOR GROUP HOLDINGS, INC. | $9K | $5.06 | +$0 | −$3K | -0.3% | $67.63B |
| UBS Group AG | $2K | $5.58 | +$2K | −$3K | -0.3% | $562.11B |
| MORGAN STANLEY | $2K | $4.91 | +$0 | +$0 | -0.3% | $1.65T |
| SIGNATUREFD, LLC | $0 | $6.19 | +$0 | +$0 | -1.1% | $6.52B |
Cost basis is a volume-weighted estimate from accumulation periods within our 13F history; holders who built their position before our window started will show a stale basis. % above the cost basis is the unrealized gain at the current price.
Trading behavior
Smart-money alpha (lifetime, %/qtr)NEUTRAL
Holders
-0.35%
avg per quarter
Holders (ex-self)
+0.06%
excl. this stock
Buyers (this Q)
-0.28%
4 buyers · $0.00B in
Sellers (this Q)
+0.00%
2 sellers · $0.00B out
alpha coverage: 65% of $ has a lifetime-alpha record
Holder behavior on this stocksource: stock
On big dips (−10%+)
-1.1%
how holders react when this stock falls
On quiet Qs
+17.0%
−10% to +10% baseline
On rallies (+10%+)
-9.6%
how they react when this stock rises
Holders' portfolio flow this Q
-16.3%
outflows — trims may be forced
Sellers' portfolio flow this Q
+4.4%
Sellers grew AUM elsewhere — opinionated cut of this stock.
▸ Compare to holder-profile behavior (across all their stocks)
Holder dip (any stock)
+0.2%
Holder mid (any stock)
+2.0%
Holder rally (any stock)
-0.6%
Biggest decreases this quarter
New buyers this quarter
Top-5 holders · 94.8%
SFI Advisors, LLC--
VANGUARD CAPITAL MANAGEMENT LLC--
MassMutual Private Wealth & Trust, FSB--
GEODE CAPITAL MANAGEMENT, LLC--
VANGUARD FIDUCIARY TRUST CO--
Top Holders Over Time
5-year share-count history (top 10 holders by peak, incl. exited) + price
hover the chart for per-quarter detailprice (right axis)
ISZO CAPITAL MANAGEMENT LP—HAMILTON LANE ADVISORS LLC—SFI Advisors, LLC165KMassMutual Private Wealth & Trust, FSB111KSEIZERT CAPITAL PARTNERS, LLC—Topline Capital Management, LLC—Maryland Capital Management—Heron Bay Capital Management—Legato Capital Management LLC—HighTower Advisors, LLC—
Analyst Coverage
Analyst Coverage
Analyst Ratings
1
Hold: 1Consensus: Hold
Corporate
Insider Trading (last 12mo)
Open-market only (Form 4 P-Purchase + S-Sale). Excludes grants, option exercises, tax withholding, gifts.
Major holders (≥10% beneficial owners)
Buys ($, 12mo)
$552K
13 txns · 1 insider · 124,381 sh
Sells ($, 12mo)
$0
0 txns · 0 insiders · 0 sh
Recent transactions
| Date | Side | Insider | Title | Shares | Price | Dollars | Owned $ |
|---|---|---|---|---|---|---|---|
| 2025-09-18 | BUY | PORTNOY DAVID | director, 10 percent owner, officer: Chairman, Co-CEO | 5,162 | $4.47 | $23K | $3.70M |
| 2025-09-17 | BUY | PORTNOY DAVID | director, 10 percent owner, officer: Chairman, Co-CEO | 5,564 | $4.43 | $25K | $3.65M |
| 2025-09-16 | BUY | PORTNOY DAVID | director, 10 percent owner, officer: Chairman, Co-CEO | 6,449 | $4.46 | $29K | $3.65M |
| 2025-09-10 | BUY | PORTNOY DAVID | director, 10 percent owner, officer: Chairman, Co-CEO | 32,317 | $4.44 | $143K | $3.60M |
| 2025-09-09 | BUY | PORTNOY DAVID | director, 10 percent owner, officer: Chairman, Co-CEO | 5,312 | $4.49 | $24K | $1.16M |
| 2025-09-08 | BUY | PORTNOY DAVID | director, 10 percent owner, officer: Chairman, Co-CEO | 5,271 | $4.31 | $23K | $1.09M |
| 2025-08-27 | BUY | PORTNOY DAVID | director, 10 percent owner, officer: Chairman, Co-CEO | 14,078 | $4.43 | $62K | $1.10M |
| 2025-08-26 | BUY | PORTNOY DAVID | director, 10 percent owner, officer: Chairman, Co-CEO | 11,101 | $4.44 | $49K | $694K |
| 2025-08-25 | BUY | PORTNOY DAVID | director, 10 percent owner, officer: Chairman, Co-CEO | 14,000 | $4.61 | $65K | $1.11M |
| 2025-08-19 | BUY | PORTNOY DAVID | director, 10 percent owner, officer: Chairman, Co-CEO | 885 | $4.37 | $4K | $593K |
| 2025-08-18 | BUY | PORTNOY DAVID | director, 10 percent owner, officer: Chairman, Co-CEO | 9,327 | $4.37 | $41K | $589K |
| 2025-08-15 | BUY | PORTNOY DAVID | director, 10 percent owner, officer: Chairman, Co-CEO | 9,089 | $4.45 | $40K | $1.05M |
| 2025-08-14 | BUY | PORTNOY DAVID | director, 10 percent owner, officer: Chairman, Co-CEO | 5,826 | $4.17 | $24K | $512K |
Order Flow (FINRA, ~3w lag)
37.7%retail+20.1pp
2.8%dark-19.0pp
week of 2026-04-13
Off-exchange volume from FINRA. Retail = non-ATS (wholesaler PFOF + broker internalization). Dark = ATS (dark-pool crossing networks, institutional). Lit-exchange = remainder.
Filing Risk Analysis
Filing Risk Scores
Cryo-Cell International: Aggressive Capital Return Amidst a Strategic Collapse and Massive Equity Deficit
Overall Risk
8/10
Fraud
5/10
Dilution
6/10
Insolvency
8/10
Earnings Overstated
7/10
Hidden Liabilities
6/10
Legal
9/10
Audit Warnings
4/10
Hidden Upside
3/10
Contextually Acceptable
2/10